Wang Zhenyi (b. 1924), hematologist-academician of the Chinese Academy of Engineering, has developed creative clinical treatments for leukemia, especially the treatment of acute promyelocytic leukemia by All Trans Retinoic Acid (Tretinoin). He was awarded China's State Supreme Science and Technology Prize in 2010.